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Abstract
Background: Although type 2 diabetes mellitus is often managed by osteopathic physicians,
osteopathic palpatory findings in this disease have not been adequately studied.
Methods: A case-control study was used to measure the association between type 2 diabetes
mellitus and a series of 30 osteopathic palpatory findings. The latter included skin changes, trophic
changes, tissue changes, tenderness, and immobility at spinal segmental levels T5–T7, T8–T10, and
T11-L2 bilaterally. Logistic regression models that adjusted for age, sex, and comorbid conditions
were used to compute odds ratios (ORs) and 95% confidence intervals (CIs) for the associations
between type 2 diabetes mellitus and each of these findings.
Results and discussion: A total of 92 subjects were included in the study. After controlling for
age, sex, hypertension, and clinical depression, the only significant finding was an association
between type 2 diabetes mellitus and tissue changes at T11-L2 on the right side (OR, 5.54; 95% CI,
1.76–17.47; P = .003). Subgroup analyses of subjects with type 2 diabetes mellitus and hypertension
demonstrated significant associations with tissue changes at T11-L2 bilaterally (OR, 27.38; 95% CI,
1.75–428; P = .02 for the left side and OR, 24.00; 95% CI, 1.51–382; P = .02 for the right side).
Among subjects with type 2 diabetes mellitus and hypertension, there was also a strong diabetes
mellitus duration effect for tissue changes at T11-L2 bilaterally (OR, 12.00; 95% CI, 1.02–141; P =
.05 for short duration vs. OR, 32.00; 95% CI, 2.29–448; P = .01 for long duration on the left side;
and OR, 17.33; 95% CI, 1.39–217; P = .03 for short duration vs. OR, 32.00; 95% CI, 2.29–448; P =
.01 for long duration on the right side).
Conclusion: The only consistent finding in this study was an association between type 2 diabetes
mellitus and tissue changes at T11-L2 on the right side. Potential explanations for this finding
include reflex viscerosomatic changes directly related to the progression of type 2 diabetes
mellitus, a spurious association attributable to confounding visceral diseases, or a chance
observation unrelated to type 2 diabetes mellitus. Larger prospective studies are needed to better
study osteopathic palpatory findings in type 2 diabetes mellitus.
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Background
Type 2 diabetes mellitus is an important public health
problem that comprises 90% to 95% of the estimated
18.2 million Americans with diabetes mellitus [1].
Although type 2 diabetes mellitus was previously called
non-insulin-dependent diabetes mellitus or adult-onset
diabetes mellitus, neither term adequately describes the
disease. Type 2 diabetes mellitus usually begins as insulin
resistance and, as the need for insulin rises, the pancreas
may lose its ability to produce insulin, thereby requiring
exogenous insulin. The prevalence of type 2 diabetes mel-
litus in children and adolescents is increasing as a conse-
quence of the continuing rise in obesity in this population
[2]. The cost of diabetes mellitus was estimated to be $132
billion in the United States during 2002, including both
medical expenditures and lost productivity [3].
Prediabetes is a term used to identify persons at high risk
of developing diabetes mellitus because they have ele-
vated fasting glucose or impaired glucose tolerance find-
ings that are not sufficiently abnormal to meet the criteria
for diagnosis of diabetes mellitus. About 41 million
Americans aged 40–74 years are estimated to have predia-
betes [1]. Identifying and intervening in persons with pre-
diabetes may help prevent or delay the progression to
diabetes mellitus and its complications, including blind-
ness, kidney damage, and lower-limb amputations.
Research that addresses osteopathic palpatory findings or
osteopathic manipulative treatment (OMT) in patients
with diabetes mellitus is scarce. The spinal segmental sites
for somatic dysfunction associated with visceral diseases,
such as diabetes mellitus, are thought to be related to the
autonomic nervous system supply for the affected organ
[4]. For example, segmental sympathetic nerve supply to
the pancreas is generally localized to T5–T11 [4]. Using a
poorly described methodology over a 25-year period, a
series of 150 diabetic and non-diabetic patients received
OMT that was intended to provide "pancreatic stimula-
tion" [5]. Baseline fasting blood glucose measures were
recorded prior to receiving OMT and were repeated 30 or
60 minutes (or both) after receiving OMT. A rapid drop in
blood glucose following OMT was reported, including
one case of hypoglycemic coma. In a complementary
phase of this study [5], 40 apparently non-diabetic
patients received OMT that was intended to provide "pan-
creatic inhibition." Baseline fasting blood glucose meas-
ures were recorded prior to receiving OMT and both 30
and 60 minutes after receiving OMT. A rapid increase in
blood glucose was reported in this phase of the study.
Results such as those described above have not been rep-
licated and reported in the contemporary osteopathic lit-
erature.
In theory, OMT for the somatic manifestations of visceral
disease may not only improve the affected paraspinal tis-
sues, but may also effect a disruption of the visceros-
omatic reflex arc, thereby creating the potential for
amelioration of the underlying visceral disease [4]. Never-
theless, clinical studies to support this theoretical concept
are lacking. The specification of osteopathic palpatory
findings associated with a particular chronic disease has
heretofore been an important barrier in performing such
studies. Thus, we conducted a case-control study to iden-
tify the osteopathic palpatory findings associated with
type 2 diabetes mellitus.
Methods
Study design
A case-control study was used to measure the association
between type 2 diabetes mellitus and various osteopathic
palpatory findings. There is a temporal lag between the
pathogenesis and progression of type 2 diabetes mellitus
and any subsequent osteopathic palpatory finding that
potentially may be detected. Therefore, the presence or
absence of type 2 diabetes mellitus was the independent
(exposure) variable and the observed osteopathic palpa-
tory findings were the dependent ("disease") variables in
this study. Thus, subjects were labelled as cases or con-
trols, respectively, if a given osteopathic palpatory finding
was present or absent. In this manner, a series of case-con-
trol analyses were performed – one for each of the 30 oste-
opathic palpatory findings described below. Subjects were
recruited for this study and enrolled between April 2002
and November 2003 at the University of North Texas
Health Science Center-Texas College of Osteopathic Med-
icine (UNTHSC-TCOM). Subjects were primarily
recruited from patients attending clinics affiliated with the
Department of Family Medicine, although some subjects
with type 2 diabetes mellitus were also recruited from
other university clinics and from the Fort Worth metro-
politan area. The Institutional Review Board at UNTHSC
approved all research procedures.
Subject eligibility was determined using a standard screen-
ing procedure for university-based clinic patients. Patients
were excluded from further participation if they met any
of the following criteria: (1) age < 18 years or age >69
years; (2) diagnosis of type 1 diabetes mellitus; (3) history
of any of the following pancreatic or related disorders: (a)
acute or chronic pancreatitis, (b) pancreatic tumor or can-
cer, (c) Zollinger-Ellison syndrome, or (d) any other med-
ical or surgical condition resulting in functional hypo- or
hyperglycemia; (4) history of surgery involving the pan-
creas; (5) current pregnancy; (6) history of pregnancy
within the last three months or intent to become pregnant
within the next six months; (7) history of back surgery
within the last three months; (8) potential contraindica-
tions to receiving OMT, including: (a) cancer other thanOsteopathic Medicine and Primary Care 2007, 1:6 http://www.om-pc.com/content/1/1/6
Page 3 of 12
(page number not for citation purposes)
non-malignant skin cancer, (b) torn tissue or hemorrhage
in the back, (c) spinal osteomyelitis, (d) spinal fracture,
(e) herniated disc, (f) ankylosing spondylitis, or (g) cauda
equina syndrome; or (9) receipt of Workers' Compensa-
tion benefits within the last three months. Several of these
exclusion criteria were primarily intended for the follow-
up study not reported herein. Identical exclusion criteria
were used for non-university-based clinic patients. All
subjects were required to provide informed consent prior
to participating in the study.
Type 2 diabetes mellitus status
Institutional medical records were used to confirm a clin-
ical diagnosis of type 2 diabetes mellitus for university-
based clinic subjects. Structured face-to-face interviews by
trained study personnel were used to confirm a diagnosis
of type 2 diabetes mellitus for non-university-based clinic
subjects. During these interviews, a comprehensive medi-
cal history was acquired, including the history of type 2
diabetes mellitus onset, progression, and current manage-
ment. The absence of type 2 diabetes mellitus in subjects
was confirmed by institutional medical records that did
not support a clinical or laboratory diagnosis of type 2
diabetes mellitus within the last year.
Osteopathic palpatory examination
Each subject was independently examined by two osteo-
pathic manipulative medicine fellows during the same
clinic visit to determine if osteopathic palpatory findings
were present or absent. The fellows in this study were
select medical students who elected to undertake an addi-
tional year of osteopathic manipulative medicine training
during their undergraduate medical curriculum. Overall,
six fellows performed these examinations during their
clinical rotations dedicated to fellowship training. Prior to
participation, fellows received training in the research
protocol provided by senior osteopathic manipulative
medicine faculty. This training included standard criteria
for determining the presence or absence of osteopathic
palpatory findings [6].
Fellows were blinded to the type 2 diabetes mellitus status
of subjects during the examination. Subjects were
instructed not to discuss any health-related matters during
the examination. Three fellow pairs were used throughout
the study to perform all osteopathic palpatory examina-
tions. In the case of discrepant osteopathic palpatory find-
ings between fellows who examined the same subject, the
findings were randomly recorded as either the first or sec-
ond fellow's set of observations for that subject.
Somatic dysfunction is defined as impaired or altered
function of related components of the somatic (body
framework) system: skeletal, arthrodial, and myofascial
structures, and related vascular, lymphatic, and neural ele-
ments [6]. The osteopathic palpatory examination in this
study assessed five elements that are manifestations of
somatic dysfunction potentially associated with a chronic
disease such as type 2 diabetes mellitus. These elements,
which often are thought to be secondary to chronic sym-
pathetic activity, included the following [7]: (1) skin
changes (coolness or paleness); (2) trophic changes (dry
or scaly skin, pimples, folliculitis, or abnormal pigmenta-
tion); (3) tissue changes (doughy, ropy, thickened, or
fibrotic interstitial tissues); (4) tenderness; and (5) immo-
bility (restricted motion). These examinations included
spinal segmental levels T5–T7, T8–T10, and T11-L2 bilat-
erally. Thus, the presence or absence of 30 osteopathic
palpatory findings (five elements of somatic dysfunction
× three ranges of spinal segmental levels × two sides) was
determined during these examinations.
Interexaminer reliability
The interexaminer reliability for each of the 30 osteo-
pathic palpatory findings was initially measured by the
crude proportional agreement between the fellows who
each examined the same subjects. Thus, this measure
could potentially range from 0 (no agreement at all) to 1
(perfect agreement). Subsequently, Cohen's kappa was
used to measure the interexaminer agreement between
fellows for each element of somatic dysfunction after
adjusting for chance agreement [8]. As with proportional
agreement, a kappa value of 1 indicates perfect agreement
between examiners. A kappa value of 0 indicates a level of
agreement between examiners that would be expected to
occur by chance alone. Unlike proportional agreement,
however, kappa can take on negative values if the
observed level of agreement between examiners is less
than that expected by chance alone. Interexaminer relia-
bility was also measured for osteopathic palpatory find-
ings aggregated according to element of somatic
dysfunction, spinal segmental level, and laterality.
Data management and analysis
Initially, we planned to include subjects with and without
type 2 diabetes mellitus who were matched according to
age, sex, and race/ethnicity. However, during the course of
the study, it became apparent that less than half of the
subjects with type 2 diabetes mellitus would have suitable
matches without type 2 diabetes mellitus. To avoid a sub-
stantial loss of statistical power, we subsequently included
all subjects, regardless of matching, and used logistic
regression to control for potential confounders. Hence,
there were substantially more subjects with than without
type 2 diabetes mellitus.
Logistic regression was used to compute the crude odds
ratios (ORs) and 95% confidence intervals (CIs) for the
associations between type 2 diabetes mellitus and each of
the 30 osteopathic palpatory findings. Age- and sex-Osteopathic Medicine and Primary Care 2007, 1:6 http://www.om-pc.com/content/1/1/6
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adjusted ORs and 95% CIs were then computed using par-
tially-adjusted logistic regression models. Finally, fully-
adjusted logistic regression models were used, which also
included commonly observed comorbid conditions as
covariates. Data analyses were performed with the Systat
(Systat Software, Inc, Point Richmond, CA, USA) and
Excel (Microsoft Corporation, Redmond, WA, USA) soft-
ware packages. Hypotheses were tested using two-tailed
assumptions at the .05 level of statistical significance.
Results
Subject characteristics
There were 60 subjects with type 2 diabetes mellitus and
32 subjects without type 2 diabetes mellitus included in
the study. The characteristics of these subjects are pre-
sented in Table 1. There were no significant differences
between subjects with and without type 2 diabetes melli-
tus with respect to sociodemographic characteristics; how-
ever, subjects with type 2 diabetes mellitus were more
likely to have hypertension (P < .001) and clinical depres-
sion (P = .05) than subjects without type 2 diabetes mel-
litus. Other comorbid conditions occurred too
infrequently to perform meaningful statistical analyses.
The median duration of type 2 diabetes mellitus since
diagnosis was five years (range, 0.1 to 25 years).
Interexaminer reliability
The overall proportional agreement (and kappa) for each
of the five elements of somatic dysfunction was: 0.69
(0.16) for skin changes; 0.66 (0.28) for trophic changes;
0.58 (0.05) for tissue changes; 0.84 (0.54) for tenderness;
and 0.62 (0.09) for immobility. The levels of interexam-
iner reliability did not vary much according to spinal seg-
mental level: 0.67 (0.34) for T5–T7, 0.67 (0.35) for T8–
T10, and 0.69 (0.36) for T11-L2. Similarly, there was little
variation in interexaminer reliability according to lateral-
ity: 0.67 (0.34) for left-, and 0.68 (0.36) for right-sided
elements of somatic dysfunction. When all palpatory find-
ings were aggregated, the interexaminer reliability was
0.68 (0.35). The interexaminer reliability of osteopathic
palpatory findings according to element of somatic dys-
function, spinal segmental level, and laterality is pre-
Table 1: Characteristics of subjects with and without type 2 diabetes mellitus.*
Diagnosis of Type 2 Diabetes Mellitus
Yes No
Subject Characteristic No. (%) No. (%) P
Age, yr† 48.8 (10.0) 49.6 (12.3) .73
Sex .25
Female 30 (50) 20 (63)
Male 30 (50) 12 (38)
Race/ethnicity .43
White 36 (60) 23 (72)
Black 20 (33) 8 (25)
Hispanic 3 (5) 0 (0)
Asian/Pacific Islander 1 (2) 1 (3)
Marital status .93
Single 18 (30) 10 (31)
Married 23 (38) 14 (44)
Separated 4 (7) 1 (3)
Divorced 12 (20) 6 (19)
Widowed 3 (5) 1 (3)
Comorbid conditions
Hypertension < .001
Yes 34 (57) 5 (16)
No 26 (43) 27 (84)
Clinical depression .05
Yes 23 (38) 6 (19)
No 37 (62) 26 (81)
*Percentages may not sum to 100 because of rounding.
†Table entries are mean (SD).Osteopathic Medicine and Primary Care 2007, 1:6 http://www.om-pc.com/content/1/1/6
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sented in Table 2. Figure 1 presents the corresponding
radar plots that illustrate the relationship between propor-
tional agreement and kappa.
Prevalence of osteopathic palpatory findings
The number of subjects with and without positive osteo-
pathic palpatory findings according to element of somatic
dysfunction, spinal segmental level, and laterality is pre-
sented in Table 3. The prevalence of these osteopathic pal-
patory findings (i.e., the proportion of subjects with
positive osteopathic palpatory findings) is depicted in Fig-
ure 2. Immobility and tissue changes were the most com-
mon osteopathic palpatory findings.
Associations between type 2 diabetes mellitus and 
osteopathic palpatory findings
The osteopathic palpatory findings according to element
of somatic dysfunction, spinal segmental level, and later-
ality are presented along with the corresponding crude
ORs and 95% CIs in Table 4. Type 2 diabetes mellitus was
significantly associated with three osteopathic palpatory
findings: tissue changes at T11-L2 on the right side (OR,
4.44; 95% CI, 1.73–11.37; P = .002); tenderness at T11-L2
on the left side (OR, 4.00; 95% CI, 1.08–14.86; P = .04);
and immobility at T5–T7 on the right side (OR, 2.56; 95%
CI, 1.05–6.25; P = .04).
As shown in Table 5, the three significant associations
between type 2 diabetes mellitus and osteopathic palpa-
tory findings persisted in the partially-adjusted logistic
regression models that controlled for age and sex: tissue
changes at T11-L2 on the right side (OR, 4.49; 95% CI,
1.69–11.96; P = .003); tenderness at T11-L2 on the left
side (OR, 4.28; 95% CI, 1.13–16.20; P = .03); and immo-
bility at T5–T7 on the right side (OR, 2.71; 95% CI, 1.09–
6.75; P = .03).
The fully-adjusted logistic regression models that control-
led for age, sex, hypertension, and clinical depression are
presented in Table 6. The only significant result in these
analyses was an association between type 2 diabetes mel-
litus and tissue changes at T11-L2 on the right side (OR,
5.54; 95% CI, 1.76–17.47; P = .003). We subsequently
performed a series of post-hoc  subgroup analyses to
explore whether tissue changes at the T11-L2 segmental
level may be manifestations of a viscerosomatic reflex
involving the kidney because its segmental sympathetic
nerve supply closely corresponds to T11-L2 [4] and it is
Table 2: Interexaminer reliability of osteopathic palpatory findings according to element of somatic dysfunction, spinal segmental 
level, and laterality.*
Element of Somatic Dysfunction Spinal Segmental Level Laterality
Left Right
Skin changes
T5–T7 0.67 (0.13) 0.73 (0.26)
T8–T10 0.66 (0.21) 0.58 (0.03)
T11-L2 0.76 (0.02) 0.78 (0.20)
Trophic changes
T5–T7 0.61 (0.23) 0.66 (0.32)
T8–T10 0.66 (0.30) 0.62 (0.16)
T11-L2 0.71 (0.32) 0.71 (0.31)
Tissue changes
T5–T7 0.55 (0.05) 0.63 (0.21)
T8–T10 0.55 (-0.07) 0.66 (0.13)
T11-L2 0.50 (-0.20) 0.59 (0.09)
Tenderness
T5–T7 0.87 (0.58) 0.86 (0.56)
T8–T10 0.85 (0.56) 0.84 (0.51)
T11-L2 0.78 (0.40) 0.85 (0.60)
Immobility
T5–T7 0.60 (-0.06) 0.57 (0.07)
T8–T10 0.69 (-0.01) 0.65 (0.07)
T11-L2 0.66 (0.23) 0.56 (0.06)
*Table entries are for proportional agreement (and kappa).Osteopathic Medicine and Primary Care 2007, 1:6 http://www.om-pc.com/content/1/1/6
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Radar plots of proportional agreement and kappa for osteopathic palpatory findings according to element of somatic dysfunc- tion, spinal segmental level, and laterality Figure 1
Radar plots of proportional agreement and kappa for osteopathic palpatory findings according to element of somatic dysfunc-
tion, spinal segmental level, and laterality. The proportional agreement is presented in yellow and kappa in gray. The red circle 
represents zero on each radial scale.
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commonly affected in the progression of type 2 diabetes
mellitus.
First, subgroups were defined according to the presence or
absence of comorbid hypertension because it is a risk fac-
tor for development of diabetic nephropathy. In subjects
with type 2 diabetes mellitus and hypertension, there
were significant associations with tissue changes at T11-L2
bilaterally in the logistic regression models that adjusted
for age, sex, and clinical depression (OR, 27.38; 95% CI,
1.75–428; P = .02 for the left side and OR, 24.00; 95% CI,
1.51–382; P = .02 for the right side). In subjects with type
2 diabetes mellitus without hypertension, no significant
associations with tissue changes at T11-L2 were observed.
Second, among subjects with type 2 diabetes mellitus with
hypertension, another stratum of subgroups was created
according to the duration of type 2 diabetes mellitus since
its diagnosis. The duration of type 2 diabetes mellitus was
defined as short (≤5 years) or long (>5 years) based on a
median split. There was a strong diabetes mellitus dura-
tion effect for tissue changes at T11-L2 bilaterally (OR,
12.00; 95% CI, 1.02–141; P = .05 for short duration vs.
OR, 32.00; 95% CI, 2.29–448; P = .01 for long duration
on the left side; and OR, 17.33; 95% CI, 1.39–217; P = .03
for short duration vs. OR, 32.00; 95% CI, 2.29–448; P =
.01 for long duration on the right side). These duration
subgroup analyses are reported as crude ORs as adjust-
ment for confounding variables was not feasible because
of the relatively small number of subjects in these sub-
group analyses.
Discussion
Tissue changes, as manifested by doughy, ropy, thickened,
or fibrotic interstitial tissue, at T11-L2 was the strongest
and most consistent osteopathic palpatory finding associ-
ated with type 2 diabetes mellitus in this study. There are
several potential explanations for this finding. First, it may
reflect other phenomena in the pathogenesis or progres-
sion of type 2 diabetes mellitus, such as diabetic nephrop-
athy. The latter would be expected to contribute to reflex
viscerosomatic changes at the T11-L2 segmental level,
albeit bilaterally [4]. Epidemiologic studies have refuted
the notion that renal prognosis is benign in type 2 diabe-
tes mellitus [9]. Most studies that assessed the presence of
diabetic nephropathy in patients with type 2 diabetes mel-
litus found that at least two-thirds of patients were
affected [10]. In fact, some patients may manifest with
Table 3: Osteopathic palpatory findings according to element of somatic dysfunction, spinal segmental level, and laterality.*
Element of Somatic Dysfunction Spinal Segmental Level Laterality
Left Right
Skin changes
T5–T7 23/69 22/70
T8–T10 27/63 27/65
T11-L2 15/76 16/76
Trophic changes
T5–T7 34/56 42/48
T8–T10 36/55 33/58
T11-L2 28/63 30/62
Tissue changes
T5–T7 57/34 53/38
T8–T10 63/28 67/24
T11-L2 64/26 62/29
Tenderness
T5–T7 17/75 17/75
T8–T10 15/74 17/73
T11-L2 21/70 22/70
Immobility
T5–T7 64/27 54/36
T8–T10 67/24 67/25
T11-L2 58/34 55/36
*Table entries are for subjects with/without a positive osteopathic palpatory finding. These subjects represent cases/controls in the study.Osteopathic Medicine and Primary Care 2007, 1:6 http://www.om-pc.com/content/1/1/6
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Columnar graphs of osteopathic palpatory findings according to element of somatic dysfunction, spinal segmental level, and lat- erality Figure 2
Columnar graphs of osteopathic palpatory findings according to element of somatic dysfunction, spinal segmental level, and lat-
erality. The columns represent the proportion of subjects with a positive osteopathic palpatory finding.
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diabetic nephropathy several years prior to a diagnosis of
diabetes mellitus. Although the clinical features of 15
such patients have been summarized [11], the incidence
rate and natural course of this phenomenon remains
unclear. Also, in our study, the significant associations
with tissue changes at T11-L2 bilaterally in subjects with
type 2 diabetes mellitus and hypertension may reflect an
augmented viscerosomatic response to two underlying
diseases that promote nephropathy.
A second possible explanation is that residual, uncon-
trolled confounding may have contributed to a spurious
association between type 2 diabetes mellitus and osteo-
pathic palpatory findings at the T11-L2 spinal segmental
level. For example, if other diseases involving the T11-L2
spinal segmental level were more often found in subjects
with type 2 diabetes mellitus than in subjects without type
2 diabetes mellitus, then these other diseases may have
spuriously inflated the observed ORs. Theoretically, the
anatomic structures most likely to be associated with oste-
opathic palpatory findings at the T11-L2 spinal segmental
level include the adrenal medulla, large intestine, appen-
dix, kidney, ureter, urinary bladder, prostate, and uterus
[4]. Subgroup analyses or multivariate modeling would
help address the issue of confounding; however, such
analyses were limited by sample size constraints.
Finally, it is possible the observed association between
type 2 diabetes mellitus and tissue changes at T11-L2 on
the right side may have simply occurred by chance and
may not be clinically related to type 2 diabetes mellitus at
all. This appears unlikely because of the strength and con-
sistency of the finding across analyses and because the
subgroup analyses of subjects with type 2 diabetes melli-
tus and hypertension not only corroborated the signifi-
cant association with tissue changes at T11-L2, but also
demonstrated that the association was much stronger and
occurred bilaterally. Additionally, among subjects with
type 2 diabetes mellitus and hypertension, a strong diabe-
tes mellitus duration effect was observed, thereby suggest-
Table 4: Crude odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between type 2 diabetes mellitus (T2DM) and 
osteopathic palpatory findings according to element of somatic dysfunction, spinal segmental level, and laterality.*
Laterality
Element of Somatic Dysfunction Spinal Segmental Level Left Right
T2DM+ T2DM- OR (95% CI) T2DM+ T2DM- OR (95% CI)
Skin changes
T5–T7 16/44 7/25 1.30 (0.47–3.58) 15/45 7/25 1.19 (0.43–3.31)
T8–T10 21/38 6/25 2.30 (0.82–6.50) 16/44 11/21 0.69 (0.27–1.75)
T11-L2 12/48 3/28 2.33 (0.61–8.99) 12/48 4/28 1.75 (0.51–5.95)
Trophic changes
T5–T7 24/35 10/21 1.44 (0.58–3.59) 27/31 15/17 0.99 (0.42–2.34)
T8–T10 25/34 11/21 1.40 (0.57–3.43) 24/35 9/23 1.75 (0.69–4.44)
T11-L2 19/40 9/23 1.21 (0.47–3.12) 22/38 8/24 1.74 (0.67–4.52)
Tissue changes
T5–T7 38/21 19/13 1.24 (0.51–3.00) 36/23 17/15 1.38 (0.58–3.29)
T8–T10 42/17 21/11 1.29 (0.51–3.25) 47/12 20/12 2.35 (0.90–6.11)†
T11-L2 45/14 19/12 2.03 (0.79–5.19) 47/12 15/17 4.44 (1.73–11.37)‡
Tenderness
T5–T7 13/47 4/28 1.94 (0.57–6.52) 13/47 4/28 1.94 (0.57–6.52)
T8–T10 11/46 4/28 1.67 (0.49–5.77) 14/44 3/29 3.08 (0.81–11.65)
T11-L2 18/42 3/28 4.00 (1.08–14.86)§ 17/43 5/27 2.13 (0.71–6.46)
Immobility
T5–T7 40/19 24/8 0.70 (0.27–1.85) 40/19 14/17 2.56 (1.05–6.25)§
T8–T10 45/14 22/10 1.46 (0.56–3.81) 45/15 22/10 1.36 (0.53–3.52)
T11-L2 39/21 19/13 1.27 (0.53–3.07) 34/25 21/11 0.71 (0.29–1.74)
*Table entries in the T2DM+ and T2DM- columns are the number of subjects with/without a positive osteopathic palpatory finding. These subjects 
represent cases/controls in the study. The ORs and 95% CIs are for risk of a positive osteopathic palpatory finding in subjects with T2DM vs. 
subjects without T2DM.
†Statistical trend, .05 ≤ P < .10
‡P = .002.
§P = .04.Osteopathic Medicine and Primary Care 2007, 1:6 http://www.om-pc.com/content/1/1/6
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ing a temporal relationship between type 2 diabetes
mellitus and subsequent tissue changes at T11-L2 bilater-
ally.
There are several limitations of this study that should be
mentioned. First, this was a case-control study with a rel-
atively small number of subjects. The inability to ade-
quately perform more subgroup analyses or to control for
additional confounders because of small sample size has
already been noted. The assessment of type 2 diabetes
mellitus status and examinations for osteopathic palpa-
tory findings were performed in a cross-sectional manner.
Although we hypothesize that osteopathic palpatory find-
ings such as tissue changes at T11-L2 may be a manifesta-
tion of viscerosomatic reflexes associated with type 2
diabetes mellitus, a temporal relationship cannot defini-
tively be established. One could argue that such osteo-
pathic palpatory findings preceded the development of
type 2 diabetes mellitus and, much like a trigger point,
may have initiated somatovisceral reflexes [12]. Neverthe-
less, with respect to temporality, the observation of a
strong diabetes mellitus duration effect for tissue changes
at T11-L2 bilaterally, in conjunction with hypertension,
provides a rationale to suggest the existence of a visceros-
omatic reflex.
Second, the osteopathic palpatory examinations were per-
formed by predoctoral osteopathic manipulative medi-
cine fellows. Although these fellows elected to take an
additional year of training in osteopathic manipulation
during their medical curriculum and received additional
study-specific training, they likely did not have the same
level of proficiency in performing osteopathic palpatory
examinations as more seasoned clinicians. Osteopathic
students have reported more palpatory findings than phy-
sicians, presumably because more experienced examiners
filter out insignificant findings [13]. A study of palpatory
diagnosis found somewhat greater agreement between
Table 5: Partially-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between type 2 diabetes mellitus 
and osteopathic palpatory findings according to element of somatic dysfunction, spinal segmental level, and laterality.*
Laterality
Element of Somatic Dysfunction Spinal Segmental Level Left Right
OR (95% CI) OR (95% CI)
Skin changes
T5–T7 1.18 (0.41–3.39) 0.99 (0.33–2.93)
T8–T10 2.31 (0.81–6.61) 0.68 (0.26–1.77)
T11-L2 2.12 (0.53–8.50) 1.81 (0.50–6.60)
Trophic changes
T5–T7 1.74 (0.65–4.67) 1.01 (0.42–2.42)
T8–T10 1.34 (0.52–3.43) 1.78 (0.68–4.65)
T11-L2 1.01 (0.36–2.80) 1.55 (0.57–4.21)
Tissue changes
T5–T7 1.22 (0.50–2.99) 1.36 (0.56–3.30)
T8–T10 1.55 (0.59–4.06) 2.46 (0.93–6.53)†
T11-L2 2.07 (0.80–5.39) 4.49 (1.69–11.96)‡
Tenderness
T5–T7 2.22 (0.64–7.68) 2.36 (0.67–8.27)
T8–T10 2.01 (0.56–7.23) 3.56 (0.91–13.88)†
T11-L2 4.28 (1.13–16.20)§ 2.39 (0.77–7.46)
Immobility
T5–T7 0.69 (0.25–1.84) 2.71 (1.09–6.75)§
T8–T10 1.44 (0.55–3.80) 1.45 (0.55–3.83)
T11-L2 1.37 (0.55–3.41) 0.79 (0.32–1.96)
*Table entries are for risk of a positive osteopathic palpatory finding in subjects with type 2 diabetes mellitus vs. subjects without type 2 diabetes 
mellitus, adjusted for age and sex.
†Statistical trend, .05 ≤ P < .10.
‡P = .003.
§P = .03.Osteopathic Medicine and Primary Care 2007, 1:6 http://www.om-pc.com/content/1/1/6
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two osteopathic physicians than between the osteopathic
physicians and a predoctoral osteopathic manipulative
medicine fellow [14].
Finally, one might argue that the reliability of osteopathic
palpatory findings reported in this study was not suffi-
ciently high to ensure validity. Our initial intent was to
have three examiners for each subject to allow for a major-
ity decision on each of the 30 osteopathic palpatory find-
ings; however, this was not logistically feasible at the time
that the study was implemented. Using kappa as a frame
of reference [15], many osteopathic palpatory findings in
this study would be classified as having fair or poor
interexaminer reliability. Four findings, all of which
involved the left side, were associated with a negative
kappa. Of these, the poorest level of agreement involved
tissue changes at T11-L2 on the left side. Such poor relia-
bility for this particular osteopathic palpatory finding may
help explain why only unilateral (i.e., right-sided) statisti-
cally significant findings were initially observed for tissue
changes at the T11-L2 spinal segmental level. Neverthe-
less, at the aggregate level, interexaminer reliability in this
study (kappa, 0.35) was comparable to that reported for
other commonly used diagnostic tests, such as exercise
electrocardiograms to identify ST-T responses (kappa,
0.30) and peripheral blood films to diagnose iron-defi-
ciency anemia (kappa, 0.39) [16]. To replicate the study
findings and overcome the limitations described above,
larger prospective studies with more experienced osteo-
pathic examiners are needed.
Conclusion
The only consistent finding in this study was an associa-
tion between type 2 diabetes mellitus and tissue changes
at T11-L2 on the right side. Potential explanations for this
finding include reflex viscerosomatic changes directly
Table 6: Fully-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between type 2 diabetes mellitus and 
osteopathic palpatory findings according to element of somatic dysfunction, spinal segmental level, and laterality.*
Laterality
Element of Somatic 
Dysfunction
Spinal Segmental Level Left Right
OR (95% CI) OR (95% CI)
Skin changes
T5–T7 0.98 (0.29–3.24) 1.12 (0.32–3.86)
T8–T10 1.88 (0.57–6.13) 0.54 (0.18–1.65)
T11-L2 1.08 (0.22–5.29) 1.08 (0.24–4.79)
Trophic changes
T5–T7 0.83 (0.26–2.66) 0.43 (0.14–1.30)
T8–T10 0.80 (0.27–2.40) 1.27 (0.42–3.84)
T11-L2 0.31 (0.08–1.18) 0.82 (0.25–2.64)
Tissue changes
T5–T7 1.01 (0.37–2.74) 1.26 (0.47–3.39)
T8–T10 1.33 (0.45–3.88) 1.95 (0.66–5.79)
T11-L2 2.24 (0.76–6.60) 5.54 (1.76–17.47)†
Tenderness
T5–T7 1.48 (0.37–6.01) 1.60 (0.40–6.45)
T8–T10 1.42 (0.34–5.94) 2.13 (0.49–9.34)
T11-L2 3.60 (0.87–14.95) 2.52 (0.72–8.82)
Immobility
T5–T7 0.73 (0.25–2.18) 2.39 (0.85–6.72)
T8–T10 1.90 (0.61–5.90) 1.45 (0.48–4.40)
T11-L2 1.13 (0.41–3.14) 0.76 (0.28–2.10)
*Table entries are for risk of a positive osteopathic palpatory finding in subjects with type 2 diabetes mellitus vs. subjects without type 2 diabetes 
mellitus, adjusted for age, sex, hypertension, and clinical depression.
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related to the progression of type 2 diabetes mellitus, a
spurious association attributable to confounding visceral
diseases, or a chance observation unrelated to type 2 dia-
betes mellitus. Larger prospective studies are needed to
better study osteopathic palpatory findings in type 2 dia-
betes mellitus.
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